Global Contraceptive Market: Size, Trends and Forecasts (2018-2022)
- Report Description Table of Contents
Scope of the Report
The report titled “Global Contraceptive Market: Size, Trends and Forecasts (2018-2022)”, provides an in depth analysis of the global contraceptive market by value, by segments, by region, etc. The report also provides a regional analysis of the contraceptive market, including the following regions: North America (the US & Canada), Europe (UK, Germany and Rest of Europe), Asia pacific and ROW.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global contraceptive market has also been forecasted for the period 2018-2022, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
The global contraceptive market is highly fragmented with many contraceptive market players operating worldwide. Some contraceptive market players operating on a local level while other contraceptive players operating on a regional and global level. The manufacturers of contraceptive market produce different type of contraceptives, some manufacturers produce contraceptive drugs, some produce contraceptive devices while other produce both contraceptive drugs and devices.
However, the competition in the global contraceptive market is dominated by few contraceptive manufacturers. Further, key players of the contraceptive market are Pfizer, Inc., Bayer AG, Merck & Co, Inc., Allergan Plc. are also profiled with their financial information and respective business strategies.
- North America
- Asia Pacific
- Pfizer, Inc.
- Bayer AG
- Merck & Co., Inc.
- Allergan Plc.
Contraception, also referred as birth control, is a method to prevent unwanted pregnancy by restraining with the normal process of fertilization with the help of drugs, barriers, devices and surgical techniques. Contraceptives are the drugs or devices which inhibit unintended pregnancy as well as Sexually Transmitted Diseases (STDs), such as chlamydia, gonorrhea, HIV/AIDS, syphilis, etc. There are various forms of contraceptives available that can be used at different times in the process. Unfortunately, there is no perfect form of contraceptive. There is a failure rate associated with the use of each and every contraceptive.
The benefits of using contraceptive are reduction in pregnancy-related risk, reduction in teenage pregnancies, population control, low risk of sexually transmitted infection, etc. The common side effects associated with the use of contraception are vomiting, weight gain, bleeding between periods or spotting, nausea, breast swelling, urinary tract infection (UTIs), allergies, etc.
Contraceptives have a long history with continuous adoption of effective contraceptives to prevent pregnancy and a shift from traditional contraceptives to modern contraceptives. Presently, contraceptive devices are used by approximately 100 million women across the globe. The contraceptive market can be segmented on the basis of product type and end-user.
The global contraceptive market has increased significantly during the years 2015-2017 and projections are made that the market would rise in the next four years i.e. 2018-2022 tremendously. The contraceptive market is expected to increase due to growing urban population, declining fertility rate, rising number of women at risk for pregnancy, increasing number of women in workforce, surging population with secondary education, etc. Yet the market faces some challenges such as, side effects associated with the contraceptive drugs and devices, lack of social acceptance, less use of contraception among the poor women, etc.